Submitted by Jim Thomas on
Jim Thomas
‘Gene drives’ seem to be the ultimate high-leverage technology. Yesterday’s report from the US National Academies begun the job of describing what is at stake, but it missed some important questions.
Jim Thomas is programme director at the ETC Group
Submitted by Joëlle Deschambault on
Coming in at over 200 pages, today’s National Academy of Sciences (NAS) report, 'Gene Drives on the Horizon’ is weighty but disappointing. It fails to properly address three of the most pressing issues raised by the controversial new technology of CRISPR-CAS9 gene drives. Dubbed, the ‘mutagenic chain reaction’ by its inventors, RNA-guided gene drives are a high-leverage synthetic biology technology invented only last year.
Submitted by Joëlle Deschambault on
Synthetic Biology, according to its proponents, is moving at five times the pace of Moore’s law – basically doubling its capabilities and halving its costs every four months. Except that brash billionaire Craig Venter, often dubbed Bioscience’s Bad Boy, is no Gordon Moore. Venter has just announced that his team has produced Synthia 3.0 – the simplest human-made and self-replicating lifeform ever. Synthia 1.0 was announced – after years of delays – in 2010 and its second coming in this new form has been awaited ever since. Synthia 2.0 slipped by without notice – apparently not much to talk about – but this new version is being hailed by at least some synthetic biology scientists as a breakthrough.
Submitted by Joana Chelo on
La Via Campesina, GRAIN and ETC Group
Submitted by Silvia Ribeiro on
The data on which is based the declaration of international emergency for the Zika virus are striking for the lack of evidence to motivate such a pompous statement by the World Health Organization (WHO) in the face of a mild illness, with very little evidence of connection with more serious ailments and without scientific proof.
Submitted by Joëlle Deschambault on
For a decade, six multinationals have controlled 75% of the world’s high-tech seeds and pesticides businesses. Late last year, Dow and DuPont agreed to merge and now state-owned ChemChina is buying Syngenta for $43 billion. This means that Monsanto needs a merger to stay in the game. Or, is the game about to be called?
Submitted by Joëlle Deschambault on
The Year that Ended Dangerously
Submitted by Joana Chelo on
The $130 billion Dow-DuPont merger announced last week has rekindled ChemChina’s $44.6 billion bid for Syngenta which, in turn, may provoke a fourth takeover try by Monsanto. If ChemChina prevails, Monsanto is likely to look for a deal with either BASF or Bayer. If they get their way, the world’s Big Six agricultural input companies controlling 75% of global agricultural R&D may be reduced to three or four.
Submitted by Joëlle Deschambault on
Paris, 11 December 2015
Seemingly out of the blue (or rather, out of the black smog of the UNFCCC process), some of the largest historical culprits for climate change, countries including the United States, Canada and the European Union, have decided to back an "ambitious goal" of limiting global temperature rise to 1.5°C. To achieve this, radical emissions cuts would be needed from now, but in the case of these countries, that's not their real intention.
Submitted by Joëlle Deschambault on
Paris, 27th November 2015 – Some of the world’s largest agro-industrial corporations will be flying the flag for ‘climate-smart agriculture’ at the upcoming Climate Summit. They will claim that hi-tech crops and intensive industrial agriculture are needed to rescue farmers (and the hungry) from a warming world – a claim widely dismissed by peasant movements and civil society groups.
Find out more about ETC Group, or contact us.